Oxidative stress in human immunodeficiency virus infection

Cellular and Molecular Life Sciences

Volumn 53, Issue 11-12, 1997, Pages 864-870

  Israel N ^a   Gougerot Pocidalo, M A ^b  

^a INSTITUT PASTEUR   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

Antioxidants; HIV infection; HIV replication; HIV transcription; Oxidative stress

Indexed keywords

ANTIOXIDANT; CD4 ANTIGEN; CYTOKINE; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REACTIVE OXYGEN METABOLITE; TRANSACTIVATOR PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFLAMMATION; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; REVIEW; SEROLOGY; T LYMPHOCYTE; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031435786     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050106     Document Type: Review

References (55)

1. Emilie D., Fior R., Jarrousse B., Marfaing K. A., Merrien D., Devergne O. et al. (1994) Cytokines in HIV infection [Review]. Int. J. Immunopharmacol. 16: 391-396
2. Eck H. P., Gmunder H., Hartmann M., Petzoldt D., Daniel V. and Droge W. (1989) Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients. Biol. Chem. Hoppe Seyler 370: 101-108
3. Buhl R., Jaffe H. A., Holroyd K. J., Wells F. B., Mastrangeli A., Saltini C. et al. (1940) Glutathione deficiency and HIV [Letter]. Lancet 335: 546
4. Staal F. J., Roederer M., Israelski D. M., Bubp J., Mole L. A., McShane D, et al. (1992) Intracellular glutathione levels in T cell subsets decrease in HIV-infected individuals. AIDS Res. Hum. Retroviruses 8: 305-311
5. Masutani H., Naito M., Takahashi K., Hattori T., Koito A., Takatsuki K. et al. (1992) Dysregulation of adult T-cell leukemia-derived factor (ADF) thioredoxin in HIV infection: loss of ADF high-producer cells in lymphoid tissues of AIDS patients. AIDS Res. Hum. Retroviruses 8: 1707-1715
6. Nakamura H., Derosa S., Roederer M., Anderson M. T., Dubs J. G., Yodoi J. et al. (1996) Elevation of plasma thioredoxin levels in HIV-infected individuals. Int. J. Immunol. 8: 603-611
7. Sonnerborg A., Carlin G., Akerlund B. and Jarstrand C. (1988) Increased production of malondialdehyde in patients with HIV infection. Scand. J. Infect. Dis. 20: 287-290
8. Revillard J. P., Vincent C. M., Favier A. E., Richard M. J., Zittoun M. and Kazatchkine M. D. (1992) Lipid peroxidation in human immunodeficiency virus infection [Letter]. J. Acquir. Immune Defic. Syndr. 5: 637-638
9. Elbim C., Prevot M. H., Bouscarat F., Franzini E., Chollet M. S., Hakim J. et al. (1994) Polymorphonuclear neutrophils from human immunodeficiency virus-infected patients show enhanced activation, diminished fMLP-induced L-selectin shedding and an impaired oxidative burst after cytokine priming. Blood 84: 2759-2766
10. Flores S. C., Marecki J. C., Harper K. P., Bose S. K., Nelson S. K. and McCord J. M. (1993) Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells. Proc. Natl. Acad. Sci. USA 90: 7632-7636
11. Westendorp M. O., Frank R., Ochsenbauer C., Stricker K., Dhein J., Walczak H. et al. (1995) Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375: 497-500
12. Levacher P. M., Gougerot P. M., Rouveix B., Kraus L. and Pocidalo J. J. (1983) Characterization of immunological depression in mice exposed to normobaric oxygen. Clin. Exp. Immunol. 54: 580-586
13. Ameisen, J. C., Groux H. and Capron A. (1992) Programmed death (apoptosis) of T CD4 lymphocytes and AIDS pathogenesis. C R Acad Sci 314: 47-50
14. Finkel T. H., Tudor W. G., Banda N. K., Cotton M. F., Curiel T., Monks C. et al. (1995) Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nature Med. 1: 129-134
15. Gougeon M. L., Lecoeur H., Dulioust A., Enouf M. G., Crouvoiser M., Goujard C. et al. (1996) Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. J. Immunol. 156: 3509-3520
16. Olivier R., Lopez O., Mollerau M., Dragic T., Guetard D. and Montagnier L. (1994) Prevention of early cell death in peripheral blood lymphocytes of HIV infected individuals by an amioxidant N Acetyl-Cysteine. In: Oxidative Stress, Cell Activation and Viral Infection, vol. I, pp. 323-332, Pasquier, C. and Olivier, R. (eds), Birkhäuser Verlag, Basel
17. Alderson M. R., Tough T. W., Davis S. T., Braddy S., Falk B., Schooley K. A. et al. (1995) Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181: 71-77
18. Brunner T., Mogil R. J., LaFace D., Yoo N. J., Mahboubi A., Echeverri F. et al. (1995) Cell-autonomous Fas (CD95) Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373: 441-444
19. Dhein J., Walczak H., Baumler C., Debatin K. M. and Krammer P. H. (1995) Autocrine T-cell suicide mediated by APO-1 (Fas CD95). Nature 373: 438-441
20. Katsikis P. D., Wunderlich E. S., Smith C. A., Herzenberg L. A. and Herzenborg L. A. (1995) Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J. Exp. Med. 181: 2029-2036
21. + T lymphocytes during HIV infection. J. Immunol. 156: 2282-2293
22. Westendorp M. O., Shatrov V. A., Schulze O. K., Frank R., Kraft M., Los M. et al. (1995) HIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state. EMBO J. 14: 546-554
23. Matsuda M., Masutani H., Nakamura H., Miyajima S., Yamauchi A., Yonehara S. et al. (1991) Protective activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U937 cells. J. Immunol. 147: 3837-3841
24. Deas O., Dumont C., Mollereau B., Metivier D., Pasquier C., Bernardpomier G. et al. (1997) Thiol-mediated inhibition of fas and cd2 apoptotic signaling in activated human peripheral T cells. Int. J. Immunol. 9: 117-125
25. Aillet F., Gougerot P. M., Virelizier J. L. and Israel N. (1994) Appraisal of potential therapeutic index of antioxidants on the basis of their in vitro effects on HIV replication in monocytes and interleukin 2-induced lymphocyte proliferation. AIDS Res. Hum. Retroviruses 10: 405-411
26. Vazeux R., Brousse N., Jarry A., Henin D., Marche C., Vedrenne C. et al. (1987) AIDS subacute encephalitis. Identification of HIV-infected cells. Am. J. Pathol. 126: 403-410
27. Ho D. D., Moudgil T. and Alam M. (1989) Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N. Engl. J. Med. 321: 1621-1625
28. + lymphocytes. Proc. Natl. Acad. Sci. USA 91: 1104-1108
29. Kopp E. B. and Ghosh S. (1995) NF-kappa B and rel proteins in innate immunity. Adv. Immunol. 58: 1-27
30. Hazan U., Thomas D., Alcami J., Bachelerie F., Israel N., Yssel H. et al. (1990) Stimulation of a human T-cell clone with anti-CD3 or tumor necrosis factor induces NF-kappa B translocation but not human immunodeficiency virus 1 enhancer-dependent transcription. Proc. Natl. Acad. Sci. USA 87: 7861-7865
31. + T cells is markedly enhanced in the setting of antisien-specific immune activation. J. Exp. Med. 183: 687-692
32. Baeuerle P. A. and Henkel T. (1994) Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12: 141-179
33. Siebenlist U., Fransozo G. and Brown K. (1994) Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10: 405-430
34. Finco T. S. and Baldwin A. S. (1995) Mechanistic aspects of NF-kappa B regulation: the emerging role of phosphorylation and proteolysis. Immunity 3: 263-272
35. Israel A. (1995) A role for phosphorylation and degradation in the control of NF-kappa B activity. Trends Genet. 11: 203-205
36. Nabel G. and Baltimore D. (1987) An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326: 711-713
37. Novogrodsky A., Ravid A., Rubin A. L. and Stenzel K. H. (1982) Hydroxyl radical scavengers inhibit lymphocyte mitogenesis. Proc. Natl. Acad. Sci. U.S.A. 79: 1171-1174
38. Chaudhri G., Clark I. A., Hunt N. H., Cowden W. B. and Ceredig R. (1986) Effect of antioxidants on primary alloantigen-induced T cell activation and proliferation. J. Immunol. 137: 2646-2652
39. Dornand, J. and Gerber M. (1989) Inhibition of murine T-cell responses by anti-oxidants: the targets of lipo-oxygenase pathway inhibitors. Immunology 68: 384-391
40. Israel N., Gougerot-Pocidalo M.-A., Aillet F. and Virelizier J. L. (1992) Redox status of cells influences constitutive or induced NF-kappa B translocation and HIV long terminal repeat activity in human T and monocytic cell lines. J. Immunol. 149: 3386-3393
41. Schreck R., Albermann K. and Baeuerle P. A. (1992) Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic. Res. Commun. 17: 221-237
42. Roederer M., Staal F. J., Raju P. A., Ela S. W., Herzenberg L. A. and Herzenberg L. A. (1990) Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. Proc. Natl. Acad. Sci. USA 87: 4884-4888
43. Kalebic T., Kinter A., Poli G., Anderson M. E., Meister A. and Fauci A. S. (1991) Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester and N-acetylcysteine. Proc. Natl. Acad. Sci. USA 88: 986-990
44. Mihm S., Ennen J., Pessara U., Kurth R. and Droge W. (1991) Inhibition of HIV-1 replication and NF-kappa B activity by cysteine and cysteine derivatives. AIDS 5: 497-503
45. Molitor J. A., Ballard D. W. and Greene W. C. (1991) Kappa B-specific DNA binding proteins are differentially inhibited by enhancer mutations and biological oxidation. New Biol. 3: 987-996
46. 2-induced T cell signal transduction. J. Biol. Chem. 269: 20718-20726
47. Sachsenmaier C., Radler P. A., Zinck R., Nordheim A., Herrlich P. and Rahmsdorf H. J. (1994) Involvement of growth factor receptors in the mammalian UVC response. Cell 78: 963-972
48. Devary Y., Gottlieb R. A., Smeal T. and Karin M. (1992) The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases. Cell 71: 1081-1091
49. Nakamura K., Hori T., Sato N., Sugie K., Kawakami T. and Yodoi J. (1993) Redox regulation of a src family protein tyrosine kinase p56lck in T cells. Oncogene 8: 3133-3139
50. Folks T. M., Justement J., Kinter A., Schnittman S., Orcnstein J., Poli G. et al. (1988) Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. J. Immunol. 140: 1117-1122
51. Bacheleric F., Alcami J., Arenzana S. F. and Virelizier J. L. (1991) HIV enhancer activity perpetuated by NF-kappa B induction on infection of monocytes. Nature 350: 709-712
52. Pantaleo G., Graziosi C., Butini L., Pizzo P. A., Schnittman S. M., Kotler D. P. et al. (1491) Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc. Natl. Acad. Sci. U.S.A. 88: 9838-9842
53. Embretson J., Zupancic M., Ribas J. L., Burke A., Racz P., Tenner R. K. et al. (1993) Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362: 359-362
54. Herzenberg L. A., Derosa S. C., Dubs J. G., Roederer M., Anderson M. T., Ela S. W. et al. (1997) Glutathione deficiency is associated with impaired survival in hiv disease. Proc. Natl. Acad. Sci. U.S.A. 94: 1967-1972
55. Gougerot-Pocidalo, M.-A., Fay M., Roche Y., Lacombe P. and Marquetty C. (1985) Immune oxidative injury induced in mice exposed to normobaric O2: effects of thiol compounds on the splenic cell sulfhydryl content and Con A proliferative response. J. Immunol. 135: 2045-2051